OMESOV

Omeprazole-based acid suppression therapy for the management of GERD

Gastro Brand

OMESOV

OMESOV contains omeprazole and is available in capsules and parenteral formulations for the management of acid-related gastro conditions.

OMESOV packshot 1
OMESOV packshot 2

Therapeutic Category

Gastro

Dosage form

Capsule and Parenteral

Strengths

20mg,40mg

Pack Sizes

pack of 10x10,1x10ml

Therapeutic Indications

  • Treatment and prevention of gastric and duodenal ulcers.
  • H. pylori eradication with appropriate antibiotics
  • Treatment and prevention of NSAID-associated ulcers
  • Treatment and long-term management of reflux oesophagitis
  • Relief of symptomatic gastro-oesophageal reflux disease (GERD)
  • Management of Zollinger–Ellison syndrome
OMESOV 20 packshot

Brand Name

OMESOV

Product Name

OMESOV 20

Generic Name

Omeprazole Capsules BP 20 mg

Dosage Form

Capsule

Pack Size

Pack of 10x10

OMESOV 20

Omeprazole Capsules BP 20 mg

View Product Information
QR code for OMESOV 20 patient information leaflet

Scan for PIL

Therapeutic Indication

  • For the treatment of acid reflux, gastric and duodenal ulcers, and other acid-related conditions.

Dosage and Method of Administration

Adults:

  • GERD symptoms: 20 mg once daily for 4–8 weeks.
  • Duodenal ulcer: 20 mg once daily for 2 weeks.
  • Gastric ulcer: 20 mg once daily for 4 weeks.
  • Prevention of recurrent gastric or duodenal ulcers: 20 mg once daily.
  • NSAID-associated gastric or duodenal ulcers: 20 mg once daily for 4–8 weeks.
  • Prevention of NSAID-associated ulcers: 20 mg once daily.

Children:

  • ≥ 1 year, weighing 10–20 kg : 20 mg once daily, if needed.
    ≥ 2 years, weighing more than 20 kg : 20 mg once daily.

Mode of Administration

  • For oral use only
OMESOV 40 packshot

Brand Name

OMESOV

Product Name

OMESOV 40

Generic Name

Omeprazole for Injection 40 mg

Dosage Form

Injection

Pack Size

Pack of 1x10ml

OMESOV 40

Omeprazole for Injection 40 mg

Therapeutic Indication

  • For the treatment of acid reflux, gastric and duodenal ulcers, and other acid-related conditions.

Dosage and Method of Administration

  • When oral treatment is not suitable : 40 mg once daily
  • Zollinger–Ellison syndrome Recommended starting dose: 60 mg once daily
  • Hepatic impairment : 10–20 mg once daily may be sufficient
  • Elderly patients: No dose adjustment required
  • Pediatric patients :Dosage not established

Mode of Administration

  • For IV use only.